Simplex Trading
BIOC

Simplex Trading’s Biocept, Inc. BIOC Stock Holding History

Simplex Trading’s Portfolio BIOC Stock Details BIOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-683
Closed -$10K – 10588
2022
Q4 		$10K Buy
683
+526
+335% +$11.6K ﹤0.01% 7596
2022
Q3 		$4K Hold
157
– – ﹤0.01% 9013
2022
Q2 		$4K Buy
+157
New +$7.15K ﹤0.01% 9077
2021
Q4 		– Sell
-133
Closed -$17K – 11764
2021
Q3 		$17K Hold
133
– – ﹤0.01% 8585
2021
Q2 		$16K Buy
133
+131
+6,550% +$17.7K ﹤0.01% 8796
2021
Q1 		$26K Buy
+2
New +$363 ﹤0.01% 7258

Other funds holding BIOC

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Simplex Trading's BIOC Position: Q2 2023 in Review

Simplex Trading sold out of Biocept, Inc. (BIOC) in Q2 2023, closing a stake of 16 shares.

Simplex Trading first reported a position in BIOC in Q1 2021 and held it in 6 quarters. The position peaked at $153K in Q1 2021. 11 funds tracked by Wall St. Rank hold BIOC as of Q2 2023.

  • Simplex Trading reported no remaining Biocept, Inc. position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 16 Biocept, Inc. shares in Q2 2023.
  • Simplex Trading first reported a position in Biocept, Inc. in Q1 2021 and held it in 6 quarters.
  • Simplex Trading's Biocept, Inc. position peaked at $153K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held Biocept, Inc. as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.